Tasly Pharmaceutical Group Co., Ltd (SHA:600535)
China · Delayed Price · Currency is CNY 14.05
+0.06 (0.43%)
Jun 9, 2026, 3:00 PM CST
SHA:600535 Market Cap
SHA:600535 has a market cap or net worth of 20.9 billion as of June 9, 2026. Its market cap has decreased by -8.14% in one year.
Market Cap
20.90B
Enterprise Value
17.83B
Revenue
8.35B
Ranking
n/a
PE Ratio
18.00
Stock Price
14.05
Market Cap Chart
Since November 3, 2004, SHA:600535's market cap has increased from 3.65B to 20.90B, an increase of 472.93%. That is a compound annual growth rate of 8.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 8, 2026 | 20.90B | -7.17% |
| Dec 31, 2025 | 22.51B | 4.22% |
| Dec 31, 2024 | 21.60B | -15.04% |
| Dec 29, 2023 | 25.43B | 59.04% |
| Dec 30, 2022 | 15.99B | -32.76% |
| Dec 31, 2021 | 23.78B | 6.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd | 23.87B |
| Zhejiang Huahai Pharmaceutical | 22.35B |
| Kangmei Pharmaceutical | 20.88B |
| Betta Pharmaceuticals | 20.57B |
| Jilin Aodong Pharmaceutical Group | 19.90B |
| Chengdu Kanghong Pharmaceutical Group | 19.65B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 19.62B |
| Hybio Pharmaceutical | 18.96B |